International Diabetes Center, Minneapolis, MN 55416 Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
1988
NCT01582282
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1988

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

psyllium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1